Integrating these findings with the flow cytometry analysis of CD8+ T cells and Treg cells within the tumor locale, it is deduced that the combination treatment group effectively reversed the tumor microenvironment compared to the IL-2 alone treatment group. This evidence concerns the gene CD8A and neoplasm.